Candesartan/Hydrochlorothiazide Side Effects

Please note - some side effects for Candesartan/Hydrochlorothiazide may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Side Effects of Candesartan/Hydrochlorothiazide - for the Consumer

Candesartan/Hydrochlorothiazide

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Candesartan/Hydrochlorothiazide:

Back pain; diarrhea; dizziness; tiredness.

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); burning, numbness, or tingling of the skin; chest pain; confusion; dark urine; decrease in sexual ability; decreased, difficult, or painful urination; eye pain; fainting; fast, slow, or irregular heartbeat; fever, chills, or persistent sore throat; light-headedness; mental or mood changes (eg, depression); muscle pain, weakness, tenderness, or cramps; numbness of an arm or leg; red, swollen, blistered, or peeling skin; restlessness; seizures; severe or persistent dizziness or drowsiness; severe or persistent dry mouth or nausea; severe stomach pain; shortness of breath; sluggishness; swelling of the arms or legs; unusual bruising or bleeding; unusual thirst, tiredness, or weakness; vision changes (eg, decreased vision clearness); vomiting; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

Side Effects by Body System - for Healthcare Professionals

Respiratory

Respiratory side effects associated with candesartan-hydrochlorothiazide have included upper respiratory tract infection (3.6%), bronchitis, sinusitis, pharyngitis, coughing, rhinitis, and dyspnea. Respiratory distress, pneumonitis, and pulmonary edema have been reported with the use of HCTZ.

Nervous system

Nervous system side effects associated with candesartan-hydrochlorothiazide have included dizziness (2.9%), vertigo, paresthesia, and hypesthesia. Restlessness has been reported with the use of HCTZ.

Musculoskeletal

Musculoskeletal side effects associated with candesartan-hydrochlorothiazide have included arthralgia, myalgia, arthrosis, arthritis, leg cramps, and sciatica. Muscle spasm has been reported with the use HCTZ.

Musculoskeletal side effects associated with angiotensin II receptor blockers including rare reports of rhabdomyolysis have been reported during postmarketing experience.

Gastrointestinal

Gastrointestinal side effects associated with candesartan-hydrochlorothiazide have included nausea, abdominal pain, diarrhea, dyspepsia, gastritis, gastroenteritis, and vomiting. Pancreatitis, jaundice (intrahepatic cholestatic jaundice), sialadenitis, cramping, constipation, gastric irritation, and anorexia have been reported with the use of HCTZ.

Metabolic

Metabolic side effects associated with candesartan-hydrochlorothiazide have included hyperuricemia, hyperglycemia, hypokalemia, increased BUN, and increased creatine phosphokinase. Electrolyte imbalance and glycosuria have been reported with the use of HCTZ.

Metabolic side effects associated with candesartan have included hypertriglyceridemia.

Hepatic

Hepatic side effects associated with candesartan-hydrochlorothiazide have included abnormal hepatic function, increased transaminase levels, and hepatitis.

Cardiovascular

Cardiovascular side effects associated with candesartan-hydrochlorothiazide have included tachycardia, palpitation, extrasystoles, bradycardia, and ECG abnormalities. Angina pectoris, myocardial infarction, and angioedema have been reported in less than 0.5% of patients. Hypotension, orthostatic hypotension, and necrotizing angiitis (vasculitis and cutaneous vasculitis) have been reported with the use of HCTZ.

Psychiatric

Psychiatric side effects associated with candesartan-hydrochlorothiazide have included depression, insomnia, and anxiety. Somnolence has been reported with the use of candesartan.

Dermatologic

Dermatologic side effects associated with candesartan-hydrochlorothiazide have included eczema, increased sweating, pruritus, and dermatitis. Photosensitivity, urticaria, purpura, exfoliative dermatitis, toxic epidermal necrolysis, and alopecia have been reported with the use of HCTZ.

Hematologic

Hematologic side effects associated with candesartan-hydrochlorothiazide have included epistaxis. Aplastic anemia, agranulocytosis, leukopenia, hemolytic anemia, and thrombocytopenia have been reported with the use of HCTZ.

Immunologic

Immunologic side effects associated with candesartan-hydrochlorothiazide have included infection and viral infection.

Ocular

Ocular side effects associated with candesartan-hydrochlorothiazide have included conjunctivitis. Transient blurred vision and xanthopsia have been reported with the use of hydrochlorothiazide. FDA has received reports of idiosyncratic reactions to the hydrochlorothiazide component resulting in acute transient myopia and acute angle-closure glaucoma.

Other

Other side effects associated with candesartan-hydrochlorothiazide have included back pain (3.3%), influenza-like symptoms fatigue, pain, peripheral edema, asthenia fever, and tinnitus. Weakness has been reported with the use of HCTZ.

Renal

Renal side effects associated with candesartan-hydrochlorothiazide have included urinary tract infection, hematuria, and cystitis. Renal failure, renal dysfunction, and interstitial nephritis have been reported with the use of HCTZ.

Renal side effects associated with candesartan have included albuminuria.

Genitourinary

Genitourinary side effects associated with HCTZ have included impotence.

Hypersensitivity

Hypersensitivity side effects associated with HCTZ have included erythema multiforme and Stevens-Johnson syndrome.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.